Gender-Affirming Hormone Therapy Abroad: How to Cross Borders Without a Dosing Gap

Missing a single week of hormone therapy abroad can reverse months of progress. Here is what customs officers, local laws, and supply chains actually mean for your trip.

Gender-affirming hormone therapy abroad: what you need to know

Customs officers do not always know what gender-affirming hormone therapy is, and in some countries the law does not recognise it as a legitimate medical category. That combination creates a specific risk: your medication gets confiscated at the border, not because it is illegal, but because the officer cannot find it in their reference system.

This article focuses on the specific friction points: which countries restrict or complicate access, what documentation actually resolves customs problems, and how to structure your supply so a one-day delay does not become a two-week gap.

Medical disclaimer: This article provides general information only and does not constitute medical or legal advice. Medication regulations and import rules change frequently. Verify current requirements with the relevant embassy, health ministry, or your prescribing clinician before you travel.

What customs officers are actually checking

Many countries permit travellers to carry a personal supply of prescription medication for up to 30 days^[1] without special import permits. Beyond that threshold, you typically need a letter from your prescribing doctor, the original pharmacy packaging, and sometimes a certified translation.

The friction for gender-affirming hormone therapy is not primarily about quantity. It is about the gap between the medication's pharmacological classification and its use case. Testosterone is a controlled or specially regulated substance in a number of countries, including the US, Canada and the UK, because of its anabolic effects and potential for misuse. Oestradiol and anti-androgens are ordinary prescription medicines in most countries, but brand availability varies.

A doctor's letter that names the INN (International Nonproprietary Name) of each medication, states your diagnosis, and confirms the prescribed dose typically resolves most border queries without escalation.

Countries where access is legally restricted or practically unavailable

Several countries have introduced legal restrictions on gender-affirming medical care that extend, in practice, to prescription access for travellers. Russia's federal ban, signed by Putin on 24 July 2023, outlaws both gender-affirming surgical procedures and hormone therapy when used for gender transition^[2], with the only carve-out being for congenital anomalies (intersex variation) treated in childhood. The law also annuls existing marriages of transgender people and prohibits legal gender marker changes. Carrying GAHT into Russia is not itself a customs offence, but accessing care, refilling prescriptions, or obtaining a bridging supply is now functionally impossible.

The Gulf states present a different risk profile. The UAE, Saudi Arabia, and Qatar do not have specific legislation targeting hormone therapy, but broad laws criminalising gender expression create legal uncertainty around possession of transition-related medication.

In contrast, Thailand, Argentina, Canada, most EU member states, and New Zealand have established clinical frameworks for gender-affirming care, and pharmacy access for travellers with valid prescriptions is generally achievable. Thailand has gender-affirming clinics in major cities such as Bangkok, where a private consultation may produce a local prescription.

The controlled substance problem with testosterone

Testosterone's legal status varies. It is a controlled substance in some countries, including the US (Schedule III), and an ordinary prescription medicine in others. Japan is a useful example of a quantity rule rather than a ban: you can bring up to one month's supply of a prescription drug without applying, but a larger supply needs an Import Confirmation (Yunyu Kakunin-sho, formerly Yakkan Shoumei) from the Regional Bureau of Health and Welfare for your airport of arrival, and the one-month allowance for injectables applies only to pre-filled syringes or self-injection kits^[3]. Apply well before travel.

For testosterone gel and injectables, check how the destination counts a month's supply, and carry the dose on your prescription so an officer can confirm the quantity matches.

Anti-androgens such as cyproterone acetate are not available in the United States but are standard prescriptions across Europe and Australia. Spironolactone, the usual US alternative, is widely available, though brand names vary. Carry the generic INN name for every medication you take.

The documentation that actually prevents confiscation

A medication passport or travel letter from your prescribing clinician should include: your full name, date of birth, the INN name of each medication, the prescribed dose, the total quantity you are carrying, and your prescriber's contact details.

For controlled substances such as testosterone, carry the original pharmacy-labelled packaging. Do not transfer medication into unlabelled containers. The pharmacy label is your primary legal identity document at the border.

If your destination country requires a certified translation, request it from your clinic at least three weeks before departure. Consulate websites for your destination country will specify whether a notarised translation is required.

Structuring your supply to survive delays

The standard advice is to carry a buffer of 10 to 14 days beyond your planned trip. That advice breaks down when your destination caps a controlled substance at a fixed allowance, such as 30 days. In that situation, carry the maximum legal allowance and treat the buffer as part of your planning, not an afterthought.

Split your supply across carry-on and checked luggage only if the controlled substance rules of your destination permit it. For most medications, the carry-on is safer: checked luggage can be lost or delayed, and temperature-sensitive formulations can be damaged in a cargo hold.

If your trip extends beyond the maximum import allowance, identify a prescriber in your destination before you leave. In countries with established gender-affirming care frameworks, such as Argentina, Spain, or Canada, a consultation at a gender clinic can produce a local prescription that covers the remainder of your stay.

Brand names differ across countries

Oestradiol valerate is sold as Progynova in many European countries and under different local brands elsewhere. Testosterone gel is sold as Testogel in Europe and as AndroGel in North America. Knowing the INN for every medication you take means a pharmacist in any country can identify an equivalent, even if your home brand is absent from their shelves. The WHO INN system standardises drug names globally^[5] for exactly this reason.

Bicalutamide is not approved for gender-affirming use in many countries, though it is used off-label. A pharmacist may refuse to dispense it without a specialist referral. Finasteride is widely available without this issue.

Why an International Patient Summary is a practical tool here

The International Patient Summary (IPS) is a structured health record format built on the HL7 FHIR standard. It lists your current medications by INN, your allergies, and your relevant diagnoses in a machine-readable format that clinicians and pharmacists in any country can interpret. The IPS is published by HL7 International^[6] as a standard for cross-border health data exchange.

For gender-affirming hormone therapy specifically, the IPS provides a clinical record that supplements your doctor's letter. A clinician in an unfamiliar country seeing your medication list can confirm dosing equivalences without having to contact your home prescriber.

Creating your IPS on Nomedic before you travel gives you a portable, structured record that is accessible offline and in any language your destination country's clinicians work in.

Cost of bridging prescriptions abroad

Consultation fees vary widely by country and clinic, so ask for the price when you book. In some countries, such as Spain, residents can access gender-affirming care through the public health system; visitors usually pay privately.

Medication costs also vary significantly between countries and between public and private pharmacies. Budget for paying the full private price if you are not covered by the local health system.

Before you travel: a practical checklist

Confirm your destination's legal status. Check whether your destination country has specific laws restricting gender-affirming medical care or possession of transition-related medications.

Get a doctor's letter with INN names. Ask your prescriber to include the INN, dose, and quantity for every medication. Request a certified translation if your destination requires it.

Carry original pharmacy packaging. Do not repackage controlled substances. The pharmacy label is your primary legal documentation at customs.

Identify a prescriber at your destination before departure. For trips longer than 30 days or to countries with controlled-substance import limits, locate a gender clinic or endocrinologist in advance.

Create your International Patient Summary. Store it on Nomedic so it is accessible offline and can be shared with any clinician regardless of their language or system.

Frequently asked questions

Can I bring testosterone through customs?

Yes, in most countries, provided you carry original pharmacy-labelled packaging and a doctor's letter naming the INN, dose and quantity. Testosterone is a controlled substance in some countries, including the US, so larger quantities can require additional documentation or an import permit.

Which countries should transgender travellers avoid?

Russia criminalised gender transition procedures in 2023, creating legal risk for travellers carrying transition-related medications. The Gulf states, including the UAE and Saudi Arabia, have broad laws around gender expression that create legal uncertainty. Check the travel advisory from your country's foreign ministry before travelling to any destination with restrictive laws.

What if my medication brand is not available at my destination?

Ask your pharmacist for the INN (International Nonproprietary Name) of each medication you take. Any pharmacist globally can use the INN to identify a local equivalent. Oestradiol valerate, testosterone gel, and bicalutamide are all available under different brand names depending on the country.

Can I get a bridging prescription abroad if my supply runs out?

In countries with established gender-affirming care, such as Thailand, Argentina, Spain and Canada, a consultation at a gender clinic or with an endocrinologist can produce a local prescription. Fees vary by country and clinic. Identify a local prescriber before your trip, not after your medication runs out.

Does cyproterone acetate cause problems at customs?

Cyproterone acetate is a prescription medication not approved in the United States, so travellers carrying it into the US may encounter unfamiliarity from customs officers. Carry a doctor's letter with the INN and your diagnosis. It is a standard prescription in most EU countries, Australia, and Thailand.

What is an International Patient Summary and why does it help?

An International Patient Summary (IPS) is a structured digital health record built on the HL7 FHIR standard. It lists your medications by INN, allergies, and diagnoses in a format any clinician globally can read. It complements your doctor's travel letter and is particularly useful when seeking emergency or bridging care abroad.

Is gender-affirming hormone therapy legal to carry across borders?

In most countries, yes, and the ordinary rule applies: a personal supply of around 30 days needs no import permit, with a prescriber's letter required beyond that^[1]. Two complications sit on top of it. Testosterone is a controlled substance in several jurisdictions, so it attracts the documentation rules that apply to controlled medicines rather than ordinary prescriptions, and customs officers do not always recognise gender-affirming hormone therapy as a medical category at all. Some countries have also introduced legal restrictions on gender-affirming care that extend, in practice, to prescription access for visitors^[2]. Carry a prescriber's letter naming each medication by INN with the dose and the clinical indication, keep everything in original labelled packaging, and check the destination's current position shortly before you travel.